seed
Stage
1
Investors
About
UPyTher B.V develops controlled-release hydrogel-drug formulations designed for the treatment of peritoneal diseases, with a focus on turning peritoneal cancer into a treatable disease through innovative therapeutics specifically designed for use in the peritoneal cavity.
Explore UPyTher B.V's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.